Loading
Life sciences · Journal article
World Journal of Pharmaceutical Research · November 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The rate of skin cancer has escalated rapidly over the past decade, affecting both melanoma and non-melanoma types. Skin cancers primarily consist of keratinocyte cancers, including cutaneous squamous cell carcinoma, basal cell carcinoma, and melanoma. This review highlights recent progress in skin cancer treatments. In addition to chemotherapy, options such as immunotherapy, targeted therapy, and photodynamic therapy (PDT) are available for skin cancer. Furthermore, the combination of PDT with chemotherapy, radiation, immunotherapy, and surgery is currently being explored. This review will focus on the pathophysiology of skin cancer and existing therapies utilized in the topical treatment of skin cancers, as well as introduce novel treatments that may offer benefits for these conditions.